This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Diabetes Mellitus  • Alert me on articles by topic

Mike Mitka

JAMA. 2006;295:2468.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Patients with diabetes can significantly reduce their risk of developing complications associated with the disease if they follow the proper medical treatment programs. But transferring that knowledge into real-world clinical settings continues to be a problem.

The latest reminder comes from a study published in the April issue of the Journal of General Internal Medicine showing that less than half of certain patients with diabetes were taking the proper medications.

A substantial proportion of patients with diabetes are not taking medications considered important for preventing complications. (Photo credit: Jill Fromer/iStockphoto.com)

Allison Rosen, MD, an assistant professor of internal medicine and health management and policy at the University of Michigan Health System in Ann Arbor, looked at a population of 742 people aged 55 years or older with self-reported diabetes, whose condition called for taking an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB). She estimated . . . [Full Text of this Article]

LONG-TERM ADHERENCE

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Kidney Failure Stabilizes after a Two-Decade Increase: Impact on Global (Renal and Cardiovascular) Health
Ruggenenti and Remuzzi
CJASN 2007;2:146-150.
FULL TEXT